3FZ-17347-99174 · OpenVSafe

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2021-02-19
Registered in v-safe
2021-02-19
Dose 1 — Pfizer-BioNTech
2021-02-19
Health check-in — day 0, dose 1
Feeling: Good · Site: Pain · Headache, Fatigue or tiredness

Adult check-in
2021-02-20
Health check-in — days 1–6 daily, dose 1
Feeling: Good · Site: Pain · None

Adult check-in
2021-02-21
Health check-in — days 1–6 daily, dose 1
Feeling: Good · None

Adult check-in
2021-02-22
Health check-in — days 1–6 daily, dose 1
Feeling: Good · None

Adult check-in
2021-02-23
Health check-in — days 1–6 daily, dose 1
Feeling: Good · None

Adult check-in
2021-02-24
Health check-in — days 1–6 daily, dose 1
Feeling: Good · None

Adult check-in
2021-02-26
Health check-in — day 7, dose 1
Feeling: Good · None

Adult check-in
2021-03-05
Survey response — day 14, dose 1
MedDRA: Chills, Pyrexia, Tremor — Feeling: Good · Be unable to work, Be unable to do your normal daily activities

Free text: Severe chills & shaking lasting eight hours, with 100 - 101 degree fever lasting two days. Onset occurring one week after first Pfizer dose injection.

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-03-12
Dose 2 — Pfizer-BioNTech
2021-03-12
Health check-in — day 0, dose 2
Feeling: Fair · Site: Pain · Headache, Fatigue or tiredness · Be unable to do your normal daily activities

Adult check-in
2021-03-13
Health check-in — days 1–6 daily, dose 2
Feeling: Good · Site: Pain · Fatigue or tiredness

Adult check-in
2021-03-14
Health check-in — days 1–6 daily, dose 2
Feeling: Good · Site: Pain · Fatigue or tiredness

Adult check-in
2021-03-15
Health check-in — days 1–6 daily, dose 2
Feeling: Good · None

Adult check-in
2021-03-16
Health check-in — days 1–6 daily, dose 2
Feeling: Good · None

Adult check-in
2021-03-17
Health check-in — days 1–6 daily, dose 2
Feeling: Good · None

Adult check-in
2021-03-18
Health check-in — days 1–6 daily, dose 2
Feeling: Good · None

Adult check-in
2021-03-19
Health check-in — day 7, dose 2
Feeling: Good · None

Adult check-in
2021-03-26
Health check-in — day 14, dose 2
Feeling: Good

Adult check-in
2021-04-02
Health check-in — day 21, dose 2
Feeling: Good

Adult check-in
2021-04-09
Health check-in — day 28, dose 2
Feeling: Good

Adult check-in
2021-04-16
Survey response — day 35, dose 2
MedDRA: Paraesthesia, Poor peripheral circulation, Reynold's syndrome, Skin discolouration — Feeling: Good

Free text: First onset of what appear to be Reynaud's symptoms: low blood flow to fingers, with whitish appearance, tingling, etc. Not sure if there is a causal relationship to the Pfizer vaccine, or just an odd coincidence. Any other reports of this?

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-04-24
Survey response — day 42, dose 2
MedDRA: Paraesthesia, Peripheral coldness, Raynaud's phenomenon, Skin discolouration — Feeling: Good

Free text: Sudden onset of Reynaud's symptoms: white/cold fingers, tingling sensation etc. May or may not be related to Pfizer vaccine.

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-06-11
Survey response — 3 months, dose 2
MedDRA: Pre-existing disease, Raynaud's phenomenon — Feeling: Good · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit

Free text: Severe ongoing Reynauds disease symptoms. Sudden onset 3 weeks after 2nd Pfizer vaccine. Timing suspicious. No such symptoms prior to vaccine.

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-06-11
Report sent to call center — 3 months, dose 2
Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional

1 call case(s)
2021-06-22
Call successful
Participant prefers to complete VAERS report online
2021-09-10
Health check-in — 6 months, dose 2
Feeling: Good

Adult check-in
2022-03-13
Health check-in — 12 months, dose 2
Feeling: Good

Adult check-in

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2021-02-19	Pfizer-BioNTech
2	2021-03-12	Pfizer-BioNTech

Call center

1 call center case

1 successful

See the call center timeline

Free text

Release 5 — day 14, dose 1

2021-03-05

Symptoms: Severe chills & shaking lasting eight hours, with 100 - 101 degree fever lasting two days. Onset occurring one week after first Pfizer dose injection.

Release 7 — day 35, dose 2

2021-04-16

Symptoms: First onset of what appear to be Reynaud's symptoms: low blood flow to fingers, with whitish appearance, tingling, etc. Not sure if there is a causal relationship to the Pfizer vaccine, or just an odd coincidence. Any other reports of this?

Release 7 — day 42, dose 2

2021-04-24

Symptoms: Sudden onset of Reynaud's symptoms: white/cold fingers, tingling sensation etc. May or may not be related to Pfizer vaccine.

Release 9 — 3 months, dose 2

2021-06-11

Symptoms: Severe ongoing Reynauds disease symptoms. Sudden onset 3 weeks after 2nd Pfizer vaccine. Timing suspicious. No such symptoms prior to vaccine.

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
SD	Chills	✓	✓	✓
SD	Paraesthesia	✓	✓	✓
SD	Peripheral coldness	✓	✓	✓
SD	Poor peripheral circulation	·	·	✓
SD	Pre-existing disease	✓	✓	✓
SD	Pyrexia	✓	✓	✓
SD	Raynaud's phenomenon	✓	✓	✓
SD	Reynold's syndrome	✓	✓	✓
SD	Skin discolouration	✓	✓	✓
SD	Tremor	✓	✓	✓

✓ active code · ○ coded but marked inactive · blank = not in that release